Quarterly report pursuant to Section 13 or 15(d)

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGE IN EQUITY

v3.23.3
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGE IN EQUITY - USD ($)
$ in Thousands
Common stock
Additional paid in capital
Accumulated other comprehensive (loss) income
Accumulated deficit
Total
Balance at the beginning of the period, shares at Dec. 31, 2021 937,547,934        
Balance at the beginning of the period at Dec. 31, 2021 $ 1,337 $ 959,611 $ (11,142) $ (743,846) $ 205,960
Increase (Decrease) in Stockholders' Equity          
Issuance of shares upon exercise of stock options $ 5 30     35
Issuance of shares upon exercise of stock options (in shares) 3,318,072        
Other comprehensive loss (gain)     1,829   1,829
Share-based compensation expense   5,586     5,586
Net loss       (50,265) (50,265)
Balance at the end of the period at Mar. 31, 2022 $ 1,342 965,227 (9,313) (794,111) 163,145
Balance at the end of the period, shares at Mar. 31, 2022 940,866,006        
Balance at the beginning of the period, shares at Dec. 31, 2021 937,547,934        
Balance at the beginning of the period at Dec. 31, 2021 $ 1,337 959,611 (11,142) (743,846) 205,960
Increase (Decrease) in Stockholders' Equity          
Net loss         (136,206)
Balance at the end of the period at Sep. 30, 2022 $ 1,394 985,312 6,683 (880,052) 113,337
Balance at the end of the period, shares at Sep. 30, 2022 982,719,936        
Balance at the beginning of the period, shares at Mar. 31, 2022 940,866,006        
Balance at the beginning of the period at Mar. 31, 2022 $ 1,342 965,227 (9,313) (794,111) 163,145
Increase (Decrease) in Stockholders' Equity          
Issuance of shares upon exercise of stock options $ 1       1
Issuance of shares upon exercise of stock options (in shares) 759,336        
Issue of shares under At The Market sales agreement, net of commission and expenses $ 44 9,932     9,976
Issue of shares under At The Market sales agreement, net of commission and expenses (in shares) 35,134,182        
Other comprehensive loss (gain)     8,270   8,270
Share-based compensation expense   5,045     5,045
Net loss       (44,520) (44,520)
Balance at the end of the period at Jun. 30, 2022 $ 1,387 980,204 (1,043) (838,631) 141,917
Balance at the end of the period, shares at Jun. 30, 2022 976,759,524        
Increase (Decrease) in Stockholders' Equity          
Issuance of shares upon exercise of stock options $ 1 5     6
Issuance of shares upon exercise of stock options (in shares) 1,005,558        
Issuance of shares upon completion of public offering, net of issuance costs $ 6 1,440     1,446
Issuance of shares upon completion of public offering, net of issuance costs (in shares) 4,954,854        
Other comprehensive loss (gain)     7,726   7,726
Share-based compensation expense   3,663     3,663
Net loss       (41,421) (41,421)
Balance at the end of the period at Sep. 30, 2022 $ 1,394 985,312 6,683 (880,052) $ 113,337
Balance at the end of the period, shares at Sep. 30, 2022 982,719,936        
Balance at the beginning of the period, shares at Dec. 31, 2022 987,109,890       987,109,890
Balance at the beginning of the period at Dec. 31, 2022 $ 1,399 990,656 (875) (909,302) $ 81,878
Increase (Decrease) in Stockholders' Equity          
Issuance of shares upon exercise of stock options $ 7 1     8
Issuance of shares upon exercise of stock options (in shares) 6,035,574        
Issue of shares under At The Market sales agreement, net of commission and expenses $ 1 187     188
Issue of shares under At The Market sales agreement, net of commission and expenses (in shares) 554,496        
Other comprehensive loss (gain)     (910)   (910)
Share-based compensation expense   1,676     1,676
Net loss       1,036 1,036
Balance at the end of the period at Mar. 31, 2023 $ 1,407 992,520 (1,785) (908,266) $ 83,876
Balance at the end of the period, shares at Mar. 31, 2023 993,699,960        
Balance at the beginning of the period, shares at Dec. 31, 2022 987,109,890       987,109,890
Balance at the beginning of the period at Dec. 31, 2022 $ 1,399 990,656 (875) (909,302) $ 81,878
Increase (Decrease) in Stockholders' Equity          
Net loss         (65,954)
Balance at the end of the period at Sep. 30, 2023 $ 1,863 1,061,420 102 (975,256) $ 88,129
Balance at the end of the period, shares at Sep. 30, 2023 1,361,595,036       1,361,595,036
Balance at the beginning of the period, shares at Mar. 31, 2023 993,699,960        
Balance at the beginning of the period at Mar. 31, 2023 $ 1,407 992,520 (1,785) (908,266) $ 83,876
Increase (Decrease) in Stockholders' Equity          
Issuance of shares upon exercise of stock options $ 1 13     14
Issuance of shares upon exercise of stock options (in shares) 698,778        
Issuance of shares upon acquisition of TCR $ 443 60,320     60,763
Issuance of shares upon acquisition of TCR (in shares) 357,429,306        
Other comprehensive loss (gain)     (1,307)   (1,307)
Share-based compensation expense   4,694     4,694
Net loss       (21,389) (21,389)
Balance at the end of the period at Jun. 30, 2023 $ 1,851 1,057,547 (3,092) (929,655) 126,651
Balance at the end of the period, shares at Jun. 30, 2023 1,351,828,044        
Increase (Decrease) in Stockholders' Equity          
Issuance of shares upon exercise of stock options $ 9 152     161
Issuance of shares upon exercise of stock options (in shares) 6,466,992        
Issuance of shares upon completion of public offering, net of issuance costs $ 3 432     435
Issuance of shares upon completion of public offering, net of issuance costs (in shares) 3,300,000        
Other comprehensive loss (gain)     3,194   3,194
Share-based compensation expense   3,289     3,289
Net loss       (45,601) (45,601)
Balance at the end of the period at Sep. 30, 2023 $ 1,863 $ 1,061,420 $ 102 $ (975,256) $ 88,129
Balance at the end of the period, shares at Sep. 30, 2023 1,361,595,036       1,361,595,036